Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 21 2 2019
medline: 1 9 2020
entrez: 21 2 2019
Statut: ppublish

Résumé

The aims of this study were to establish cardiac rehabilitation availability and density, as well as the nature of programmes, and to compare these by European region (geoscheme) and with other high-income countries. A survey was administered to cardiac rehabilitation programmes globally. Cardiac associations were engaged to facilitate programme identification. Density was computed using global burden of disease study ischaemic heart disease incidence estimates. Four high-income countries were selected for comparison ( Cardiac rehabilitation was available in 40/44 (90.9%) European countries. Data were collected in 37 (94.8% country response rate). A total of 455/1538 (29.6% response rate) programme respondents initiated the survey. Programme volumes (median 300) were greatest in western European countries, but overall were higher than in other high-income countries ( European cardiac rehabilitation capacity must be augmented. Where available, services were consistent with guidelines, but varied regionally.

Identifiants

pubmed: 30782007
doi: 10.1177/2047487319827453
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1131-1146

Commentaires et corrections

Type : CommentIn

Auteurs

Ana Abreu (A)

1 Cardiology Department, Hospital Santa Maria, Portugal.

Ella Pesah (E)

2 Department of Kinesiology and Health Sciences, York University, Canada.

Marta Supervia (M)

3 Physical Medicine and Rehabilitation, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute, Spain.

Karam Turk-Adawi (K)

4 Department of Public Health, Qatar University, Qatar.

Birna Bjarnason-Wehrens (B)

5 Institute for Cardiology and Sports Medicine, German Sport University Cologne, Germany.

Francisco Lopez-Jimenez (F)

6 Department of Cardiovascular Medicine, Mayo Clinic, USA.

Marco Ambrosetti (M)

7 Istituti Clinici Scientifici Maugeri, Care and Research Institute Department of Cardiac Rehabilitation, Italy.

Karl Andersen (K)

8 Department of Internal Medicine, University of Iceland, Iceland.

Vojislav Giga (V)

9 Institute of Cardiovascular Diseases, Clinical Center of Serbia, Serbia.

Dusko Vulic (D)

10 University of Banja Luka, Center for Medical Research, Bosnia and Herzegovina.

Eleonora Vataman (E)

11 Institute of Cardiology, Moldova Academy of Science, Republica Moldova.

Dan Gaita (D)

12 University of Medicine and Pharmacy "Victor Babes", Cardiovascular Prevention and Rehabilitation Clinic, Romania.

Jacqueline Cliff (J)

13 Cardiac Rehabilitation Department, Betsi Cadwaladr University Health Board, Wrexham Maelor Hospital, UK.

Evangelia Kouidi (E)

14 Department of First Internal Medicine, Aristotle University of Thessaloniki, Greece.

Ilker Yagci (I)

15 Physical Medicine and Rehabilitation Department, Marmara University School of Medicine, Turkey.

Attila Simon (A)

16 Cardiac Rehabilitation Department, State Hospital for Cardiology, Hungary.

Arto Hautala (A)

17 Cardiovascular Research Group, Oulu University Hospital, Finland.

Egle Tamuleviciute-Prasciene (E)

18 Department of Rehabilitation, Lithuanian University of Health Sciences, Lithuania.

Hareld Kemps (H)

19 Department of Cardiology, Maxima Medical Centre, The Netherlands.

Zbigniew Eysymontt (Z)

20 Cardiac Rehabilitation Department, Ślaskie Centrum Rehabilitacji w Ustroniu, Poland.

Stefan Farsky (S)

21 Cardiology Department, Heart House Martin, Slovakia.

Jo Hayward (J)

22 Cardiology Department, Norfolk and Norwich University Hospital, UK.

Eva Prescott (E)

23 Cardiology Department, Bispebjerg Frederiksberg Hospital, Denmark.

Susan Dawkes (S)

24 School of Health and Social Care, Edinburgh Napier University, UK.

Bruno Pavy (B)

25 Cardiac Rehabilitation Department, Loire-Vendée-Océan Hospital, France.

Anna Kiessling (A)

26 Karolinska Institutet, Department of Clinical Sciences Danderyd Hospital, Sweden.

Eliska Sovova (E)

27 Department of Internal Medicine, University of Palacky, University Hospital Olomouc, Czech Republic.

Sherry L Grace (SL)

2 Department of Kinesiology and Health Sciences, York University, Canada.
28 Toronto Rehabiliation Institute, University Health Network, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH